APA (7th ed.) Citation

R, K., R, P., A, C., B, B., J, P., C, J., . . . S, B. (2026). Real-World Infectious Outcomes with Dupilumab Compared with Proton Pump Inhibitors and Topical Steroids in Eosinophilic Esophagitis: A Multi-cohort Propensity Matched Analysis. Digestive diseases and sciences. https://doi.org/10.1007/s10620-026-09949-9

Chicago Style (17th ed.) Citation

R, Kaul, Prado R, Chatterjee A, Baggott B, Philpott J, Jansson-Knodell C, Qin Y, Beveridge C, and Bhat S. "Real-World Infectious Outcomes with Dupilumab Compared with Proton Pump Inhibitors and Topical Steroids in Eosinophilic Esophagitis: A Multi-cohort Propensity Matched Analysis." Digestive Diseases and Sciences 2026. https://doi.org/10.1007/s10620-026-09949-9.

MLA (9th ed.) Citation

R, Kaul, et al. "Real-World Infectious Outcomes with Dupilumab Compared with Proton Pump Inhibitors and Topical Steroids in Eosinophilic Esophagitis: A Multi-cohort Propensity Matched Analysis." Digestive Diseases and Sciences, 2026, https://doi.org/10.1007/s10620-026-09949-9.